Levin A.; Reporting Standards and the Transparency of Trials. Ann Intern Med. 2001;134:169-172. doi: 10.7326/0003-4819-134-2-200101160-00025
Download citation file:
Published: Ann Intern Med. 2001;134(2):169-172.
“Nobody sets out to write a bad paper,” said Curtis L. Meinert, PhD, professor of epidemiology and biostatistics at the Johns Hopkins School of Hygiene and Public Health in Baltimore. Yet far too many reports of clinical trials have lacked so much vital information that they are virtually unusable as guides for treating patients or planning policy. “There is a lack of detail in published reports that is due partly to authors and partly to editors,” said Meinert.
To bridge the gap between what a trial should report and what is actually published, a small group of researchers, epidemiologists, statisticians (including Meinert), and journal editors have met over the past 7 years to develop the Consolidated Standards of Reporting Trials (CONSORT), a set of guidelines that include a checklist and a model flow diagram, to help biomedical researchers report the results of randomized, controlled clinical trials fully and accurately. The first version of CONSORT appeared in 1996, and a major revision, which was completed in fall 2000, will soon be published. A detailed explanatory article giving the rationale for each item included in the reporting checklist and the empiric evidence that supports the importance of that item will accompany the revised CONSORT statement.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Infectious Disease, Ethics, Mycobacterial Infections.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only